These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6698828)

  • 1. Studies of variation in inherent sensitivities to radiation, 5-fluorouracil and methotrexate in a series of human and murine tumor cell lines in vitro.
    Bellamy AS; Whelan RD; Hill BT
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):87-93. PubMed ID: 6698828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of radiation and 5-fluorouracil, cyclophosphamide or methotrexate in intestinal crypt cells.
    von der Maase H
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):77-86. PubMed ID: 6698827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate.
    Hill BT; Shellard SA; Hosking LK; Dempke WC; Fichtinger-Schepman AM; Tone T; Scanlon KJ; Whelan RD
    Cancer Res; 1992 Jun; 52(11):3110-8. PubMed ID: 1591724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of collateral sensitivity to cisplatin, methotrexate, and fluorouracil in a human ovarian carcinoma cell line following exposure to fractionated x-irradiation in vitro.
    Dempke WC; Hosking LK; Hill BT
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):66-72. PubMed ID: 1557659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation and thermal sensitivities of murine tumor (FSa-II) cells recurrent after a heavy irradiation.
    Majima H; Urano M; Sougawa M; Kahn J
    Int J Radiat Oncol Biol Phys; 1992; 22(5):1019-28. PubMed ID: 1555947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance following irradiation of RIF-1 tumors: influence of the interval between irradiation and drug treatment.
    Hopwood LE; Davies BM; Moulder JE
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):643-50. PubMed ID: 2211211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of 5-fluorouracil radiosensitivity modulation in cultured mammalian cell lines.
    Smalley SR; Kimler BF; Evans RG; Dalziel WC
    Int J Radiat Oncol Biol Phys; 1992; 24(3):519-25. PubMed ID: 1399739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine L5178Y cells resulting in altered drug sensitivities from fractionated radiation exposure in vitro.
    Bellamy AS; Hill BT
    J Natl Cancer Inst; 1984 Feb; 72(2):411-7. PubMed ID: 6582326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of folylpolyglutamate synthetase modulation on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate.
    Sohn KJ; Smirnakis F; Moskovitz DN; Novakovic P; Yates Z; Lucock M; Croxford R; Kim YI
    Gut; 2004 Dec; 53(12):1825-31. PubMed ID: 15542523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro responses of human prostate tumour cell lines to a range of antitumour agents.
    Metcalfe SA; Whelan RD; Masters JR; Hill BT
    Int J Cancer; 1983 Sep; 32(3):351-8. PubMed ID: 6885184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of human cancer cell lines as a primary screening system for antineoplastic compounds.
    Finlay GJ; Baguley BC
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):947-54. PubMed ID: 6540194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines. II: In vivo radioresponse following fractionated treatment and in vitro/in vivo correlations.
    Bristow RG; Hill RP
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):331-45. PubMed ID: 2303364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical adjuvant therapy in colon carcinoma: a human tumor spheroid model for evaluating radiation sensitizing agents.
    Barone RM; Calabro-Jones P; Thomas TN; Sharp TR; Byfield JE
    Cancer; 1981 May; 47(10):2349-57. PubMed ID: 7272891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation induction of drug resistance in RIF-1: correlation of tumor and cell culture results.
    Moulder JE; Hopwood LE; Volk DM; Davies BM
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):213-6. PubMed ID: 1991681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo radiation sensitivity of glioblastoma multiforme.
    Taghian A; DuBois W; Budach W; Baumann M; Freeman J; Suit H
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):99-104. PubMed ID: 7721644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines.
    Vokes EE; Beckett M; Karrison T; Weichselbaum RR
    Oncology; 1992; 49(6):454-60. PubMed ID: 1465284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of stromal sensitivity on radiation response of tumors.
    Budach W; Taghian A; Freeman J; Gioioso D; Suit HD
    J Natl Cancer Inst; 1993 Jun; 85(12):988-93. PubMed ID: 8496984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
    Zhen YS; Taniki T; Weber G
    Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of 5-fluorouracil and methotrexate to destroy the reproductive integrity of a human breast cancer cell line (MCF-7) growing in vitro.
    Van den Berg HW; Clarke R; Murphy RF
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1275-81. PubMed ID: 7200028
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiosensitization of cultured human colon adenocarcinoma cells by 5-fluorouracil: effects on cell survival, DNA repair, and cell recovery.
    Hughes LL; Luengas J; Rich TA; Murray D
    Int J Radiat Oncol Biol Phys; 1992; 23(5):983-91. PubMed ID: 1639656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.